NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

ttubular,

OCEA won’t disrupt the cancer treatment environment enough to make it worth keeping it from moving ahead right now. NWBO on the other hand has the potential to change big pharma leadership positions and profitability worldwide. That kind of threat touches many in various fields beyond big pharma including smaller biotechs, investment funds, medical research, media, government, finance etc.
Anyone who has not been following this science or ticker for a while or is not a very quick study won’t likely catch up to what is going on with any level of confidence near to what those of us long timers have because of what we have learned, seen and experienced.
Bottom line is this is transformational science, validated by top line data and published peer review in JAMA Oncology. We wait on the approval process to play out and perhaps for additional trouble coming from the DOJ investigation, announced last year, for stock manipulators including perhaps those working against NWBO. Best wishes.